# Arcascope

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arcascope

- Industry: Healthcare IT
- Headquarters: Chantilly, US
- Website: www.arcascope.com
- Total disclosed funding: $1.9M
- Latest round: Seed (Jun 3, 2022)
- Investors on record: 8

## About

Founded in 2019 and based in Virginia, US, Arcascope, Inc. operates as a developer of a medical software platform that enables users to track their overall physical health and generates solutions to retain and improve their health. In June 2022, Arcascope, Inc. raised USD 1.95 million in seed funding led by investor Supermoon Capital, with participation from Accelerate Blue Fund, AIoT Health, HealthX Ventures, Inception Health, Inflect Health, Monroe-Brown Foundation, and New Dominion Angels. As of August 2023, the company is being led by its CEO, Olivia Walch.



The firm develops and offers mobile and web-based applications that leverage signals from wearable devices and utilizes algorithms to track the circadian rhythms of individuals to track and trace any anomalies in real-time and rhythm disruptions caused due to lifestyle changes. The firm helps to generate personalized recommendations, personalized behavioral recommendations, and environmental integrations for users based on the data collected to help individuals to retain their health.

## Funding rounds

- Seed, Jun 3, 2022, $1.9M — New Dominion Angels, HealthX Ventures, AIoT Health, Supermoon Capital, Inflect Health, Inception Health, Accelerate Blue Fund, Monroe-Brown Foundation

## Investors

- New Dominion Angels — Seed
- HealthX Ventures (https://capitalatlas.ai/funds/healthx-ventures) — Seed
- AIoT Health (https://capitalatlas.ai/funds/aiot-health) — Seed
- Supermoon Capital (https://capitalatlas.ai/funds/supermoon-capital) — Seed
- Inflect Health (https://capitalatlas.ai/funds/inflect-health) — Seed
- Inception Health — Seed
- Accelerate Blue Fund — Seed
- Monroe-Brown Foundation — Seed